Guy Hermans News Today

UTRECHT, The Netherlands--(BUSINESS WIRE)--Sapreme, a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutics, today announced the appointment of experienced biopharmaceutical industry executives Jeanne Bolger, MD, and Andre Hoekema, PhD, to its Board of Directors. Both bri...

Sapreme Technologies discuss novel bioconjugation methods to incorporate specific cell-targeting and membrane-penetrating mechanisms.

-- Proceeds to support continued platform scaling, progress therapeutic leads toward preclinical proof of concept -- Sapreme, a biotechnology company focused on improving the delivery and efficacy

Sapreme Appoints Henrik Luessen as Chief Business Officer Sapreme, a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutics, today announced the appointment of Henrik L. Luessen, Ph.D., as Chief Business Officer. In this role, Dr. Luessen will advise Sapreme in its business development, partnerships and funding activities, and will report to Guy Hermans, Ph.D., Chief Executive Officer. "Henrik brings strong experience with emerging biotechnology c...

Sapreme Appoints Björn Cochlovius as Chairman of its Board of Directors Sapreme, a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutics, today announced the establishment of its independent Board of Directors by the appointment of Björn Cochlovius, Ph.D., as Chairman of the Board, effective immediately. "Björn is a pharma industry veteran with both a deep understanding of oncology research and antibody engineering as well as a strong track re...